Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 GBX | -.--% | -37.78% | -91.08% |
04-15 | Investors show nerves after Iran launches drones | AN |
04-15 | Molecular Energies shares plummet as company to delist from UK markets | AN |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 137.5 | 125.8 | 45.16 | 49.81 | 54.3 | 17.42 |
Enterprise Value (EV) 1 | 154.6 | 154 | 68.35 | 68.8 | 84.51 | 58.49 |
P/E ratio | -14.2 x | 1,173 x | -0.5 x | -3.57 x | 12 x | -1.66 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 7.66 x | 2.67 x | 1.11 x | 1.79 x | 1.59 x | 0.52 x |
EV / Revenue | 8.62 x | 3.26 x | 1.67 x | 2.48 x | 2.47 x | 1.76 x |
EV / EBITDA | -71.2 x | 8.65 x | 6.45 x | 314 x | 15.9 x | 10.1 x |
EV / FCF | -6.33 x | -17.5 x | 2.19 x | -3.09 x | -5.56 x | -6.74 x |
FCF Yield | -15.8% | -5.7% | 45.6% | -32.4% | -18% | -14.8% |
Price to Book | 0.94 x | 0.86 x | 0.71 x | 0.65 x | 0.79 x | 0.3 x |
Nbr of stocks (in thousands) | 5,360 | 5,364 | 5,676 | 10,118 | 10,290 | 10,290 |
Reference price 2 | 25.65 | 23.46 | 7.956 | 4.923 | 5.276 | 1.693 |
Announcement Date | 18-06-07 | 19-05-31 | 20-06-25 | 21-08-28 | 22-06-30 | 23-06-30 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 17.94 | 47.18 | 40.81 | 27.77 | 34.15 | 33.23 |
EBITDA 1 | -2.173 | 17.81 | 10.59 | 0.219 | 5.308 | 5.811 |
EBIT 1 | -8.001 | 13.12 | -87.49 | -11.15 | -5.188 | -12.2 |
Operating Margin | -44.59% | 27.82% | -214.37% | -40.16% | -15.19% | -36.7% |
Earnings before Tax (EBT) 1 | -13.24 | 6.08 | -93.56 | -10.25 | 5.704 | -12.17 |
Net income 1 | -8.798 | 0.12 | -88.28 | -11.28 | 4.579 | -10.5 |
Net margin | -49.03% | 0.25% | -216.3% | -40.64% | 13.41% | -31.59% |
EPS 2 | -1.812 | 0.0200 | -15.81 | -1.380 | 0.4400 | -1.020 |
Free Cash Flow 1 | -24.44 | -8.778 | 31.16 | -22.28 | -15.2 | -8.679 |
FCF margin | -136.22% | -18.6% | 76.34% | -80.21% | -44.52% | -26.11% |
FCF Conversion (EBITDA) | - | - | 294.21% | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 18-06-07 | 19-05-31 | 20-06-25 | 21-08-28 | 22-06-30 | 23-06-30 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 17.1 | 28.1 | 23.2 | 19 | 30.2 | 41.1 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -7.884 x | 1.58 x | 2.19 x | 86.72 x | 5.693 x | 7.066 x |
Free Cash Flow 1 | -24.4 | -8.78 | 31.2 | -22.3 | -15.2 | -8.68 |
ROE (net income / shareholders' equity) | -5.99% | 0.08% | -83.9% | -16.1% | 6.31% | -16.5% |
ROA (Net income/ Total Assets) | -2.71% | 4.07% | -33% | -5.93% | -2.64% | -5.69% |
Assets 1 | 325 | 2.947 | 267.3 | 190.4 | -173.3 | 184.6 |
Book Value Per Share 2 | 27.20 | 27.30 | 11.30 | 7.550 | 6.690 | 5.680 |
Cash Flow per Share 2 | 0.7500 | 0.3700 | 0.1600 | 0.1100 | 0.2000 | 0.7700 |
Capex 1 | 12.4 | 8.42 | 12.9 | 11.6 | 21.1 | 21.8 |
Capex / Sales | 69.11% | 17.85% | 31.59% | 41.65% | 61.74% | 65.69% |
Announcement Date | 18-06-07 | 19-05-31 | 20-06-25 | 21-08-28 | 22-06-30 | 23-06-30 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-91.08% | 1.08M | |
+7.76% | 294B | |
+5.32% | 146B | |
+55.38% | 128B | |
+17.95% | 80.27B | |
+8.97% | 74.75B | |
+19.90% | 62.53B | |
+8.29% | 57.13B | |
+9.99% | 48.14B | |
+27.44% | 34.96B |
- Stock Market
- Equities
- PPC Stock
- Financials Molecular Energies PLC